Back to Search
Start Over
United Kingdom,United States : SK bioscience and GSKs adjuvanted COVID-19 vaccine candidate meets coprimary objectives in a phase III study; Biologics License Application submitted for SKYCovione(GBP510|GSK adjuvant) in South Korea
- Source :
- Mena Report. May 4, 2022
- Publication Year :
- 2022
-
Abstract
- Recombinant protein-based GBP510 with GSK pandemic adjuvant demonstrates superior neutralising titres compared to a control vaccine and clinically favourable safety profile SK submits license application to MFDS to support vaccine [...]
Details
- Language :
- English
- ISSN :
- 22190112
- Database :
- Gale General OneFile
- Journal :
- Mena Report
- Publication Type :
- News
- Accession number :
- edsgcl.702493689